Advanced squamous lung cancer: therapeutic options, future directions, unmet needs and results of a monocentric survey.

ABSTRACT: Lung cancer is the leading cause of cancer-related deaths in worldwide, and NSCLC represents around 85% of all lung cancers. Squamous cell lung cancer (SqCLC) is the second most common subtype and it is challenging to treat. New options have been discovered but progresses are still limited for the lack of 'druggable' mutations. Specific resources for SqCLC are limited and this condition affects treatment and outcomes. This paper describes available and emerging therapeutic options and resources that may help patients to face their disease. We have also performed a monocentric survey collecting information about smoking habit and sense of guilty and analyzed the possibility for patients to find helpful sources for their disease. The results suggest that more materials focused on SqCLC are still needed.

SUBMITTER: Bertaglia V 

PROVIDER: S-EPMC6310352 | biostudies-other | 2017 Dec

REPOSITORIES: biostudies-other